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Xenopus nuclear factor 7 (xnf7) is a maternally expressed nuclear protein that is retained in the cytoplasm from oocyte
maturation until the midblastula transition (MBT). Mutations of the xnf7 phosphorylation sites to glutamic acids (dnxnf7)
resulted in the retention of the endogenous protein in the cytoplasm past the MBT, indicating that cytoplasmic retention
is a phosphorylation dependent process. In addition, dnxnf7 acted as a dominant negative mutant by keeping the endogenous
xnf7 protein in the cytoplasm past the MBT. Overexpression of dnxnf7 in future dorsal blastomeres resulted in a ventralized
or posteriorized phenotype in which the embryos lacked anterior structures, while overexpression in ventral blastomeres
resulted in dorsalized embryos. dnxnf7 also affected the expression of both dorsal and ventral mesodermal markers. These
data suggest that xnf7 functions in dorsal/ventral patterning and that the movement of the protein from the cytoplasm to
the nucleus at the MBT is critical for the execution of a genetic program conferring a dorsal or ventral identity to the
mesoderm. q 1997 Academic Press
INTRODUCTION Kessler and Melton, 1995) or Xwnt11 (Ku and Melton, 1993)
are likely candidates to initiate the process by producing a
prepatterning of the embryo that is later elaborated uponThe unfertilized Xenopus egg is spherical with an animal/
by the sequential action of other growth factors such as FGFvegetal polarity but no overt signs of the impending estab-
(Kimelman et al., 1988), activin-like molecules (Asashimalishment of dorsal/ventral or anterior/posterior axial polari-
et al., 1990; Smith et al., 1990; Thomsen et al., 1990), BMPties. Therefore, an important problem in the ®eld of verte-
(Jones et al., 1992; Dale et al., 1992; Koster et al., 1991),brate development has been to understand the mechanism
and Xwnt family members (Christian et al., 1991; Smithresponsible for the manifestation of the dorsal/ventral and
and Harland, 1991; Cui et al., 1995; reviewed by Sive, 1993;anterior/posterior polarities during embryogenesis. It is
Slack, 1994; Dawid, 1994).known that immediately after fertilization dorsal±ventral
Activin, FGF, and BMP growth factors function throughpolarity is initiated with the rotation of the cortex (Gerhart
signal transduction pathways involving receptors and a cas-et al., 1989). The cortical movement leads to the formation
cade of kinase and phosphatase regulatory componentsof an early dorsalizing center, the Nieuwkoop center, that
(Amaya et al., 1991; Gotoh et al., 1995; Graves et al., 1994;induces the overlying marginal zone cells to form meso-
Hartley et al., 1994; LaBonne et al., 1995; He et al., 1995;derm. During gastrulation the dorsal lip or Spemann's orga-
Northrop et al., 1995). These pathways undoubtedly regu-nizer marks the site through which the dorsal mesoderm
late the expression of region-speci®c factors that impose ainvolutes; the leading edge of the dorsal mesoderm marks
more rigid patterning of the gastrula stage embryo and di-the anterior of the embryo.
vide it into overlapping yet distinct domains. These do-The dorsal±ventral (D/V) and anterior±posterior (A/P)
mains consist of a growing list of genes that includepatterning of the mesoderm in the Xenopus embryo is under
goosecoid (Cho et al., 1991), noggin (Smith and Harland,the control of secreted growth factor-like molecules. Local-
1992), Xlim (Taira et al., 1992), Xcad (Blumberg et al., 1991),ized maternally expressed factors such as Vg1 (Weeks and
Xotx (Simeone et al., 1993), Xnot (Von Dassow et al., 1993),Melton, 1987; Thomsen and Melton, 1993; Dale et al., 1993;
Xwnt11 (Ku and Melton, 1993), forkhead (Dirksen and Jam-
rich, 1992; Knochel et al., 1992; Ruiz i Altaba and Jessel,
1992), Siamois (Lemaire et al., 1995), Nodal-related (Smith1 Present address: Dept. of Pathology, Baylor College of Medicine,
et al., 1995), and chordin (Sasai et al., 1994) in the Spe-Houston, TX 77030.
2 To whom correspondence should be addressed. mann's organizer region, Xbra in the mesoderm ring (Smith
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et al., 1991), and Xwnt8 (Christian et al., 1991; Smith and in the retention of the exogenous xnf7 in the cytoplasm
after the MBT, while the xnf7thr-ala mutation resulted inHarland, 1991), Xpo (Sato and Sargent, 1991), and Xvent1
(Gawantka et al., 1995) in the ventral/posterior region. A entry of the protein into the nucleus prior to the MBT (Li
et al., 1994a; Shou et al., 1996).key to understanding the process of pattern formation in
vertebrates is to identify the molecules that are responsive In the present study we show that the overexpressed exog-
enous mutant dnxnf7 was capable of inhibiting the translo-to growth factor signaling and regulate the expression of
the downstream genes for region-speci®c factors involved cation of endogenous xnf7 into the nucleus at the MBT,
thus acting as a dominant-negative mutant. The inabilityin D/V and A/P patterning. Indeed, recent evidence points
to several signal transduction pathways and components of the endogenous xnf7 to enter the nucleus at the MBT
resulted in two phenotypes consisting of ventralized andsuch as GSK-3 (He et al., 1995; Pierce and Kimelman, 1995),
MAP kinase (Gotoh et al., 1995; LaBonne et al., 1995; Umb- dorsalized embryos. The prevalence of one or the other phe-
notype was dependent on the site of injection. Ventralizedhauer et al., 1995; Hartley et al., 1994), and TGFb/Smad
(Graff et al., 1996; Baker and Harland, 1996) being involved embryos were produced when the dnxnf7 RNA was injected
into the dorsal blastomeres. Injection into the ventral blas-in mesoderm induction and patterning of the early embryo.
In the amphibian, early development prior to the MBT is tomeres of the four cell embryo resulted in dorsalized em-
bryos. In addition, we demonstrate that the overexpressiondirected strictly by maternal gene products. A series of cru-
cial developmental events occur at the MBT, including the of dnxnf7 alters the expression patterns of the panmesoder-
mal marker Xbra, the dorsal marker chordin and the ventralinitiation of zygotic transcription, changes in the cell cycle,
and the initiation of cellular movement (Newport and markers Xwnt8 and Xvent1. We suggest that the entry of
xnf7 into nuclei at the MBT is necessary for the regulationKirschner, 1982a,b; Etkin, 1988). Dreyer et al. (1983) de-
scribed the developmental fate of a number of maternal of genes that are required for normal dorsal±ventral pat-
terning.nuclear proteins in Xenopus laevis that were ®rst detected
in the oocyte nucleus (GV). Following oocyte maturation
these proteins are released into the cytoplasm; after fertil-
ization, some immediately reenter the nucleus (early shift- MATERIALS AND METHODSing), while others remain in the cytoplasm until speci®c
stages during development (late shifting). Several of the late-
Expression Vectorsshifting proteins reenter the nucleus at the MBT and gas-
trula stages and therefore may play important roles in regu-
xnf7 mRNA expression vector consisted of pBS or pSP72, intolating developmental processes such as axial patterning.
which a synthetic oligonucleotide containing the 5* untranslated
One of the late-shifting proteins, xnf7 (Xenopus nuclear sequences of the Xenopus b-globin gene and a 12-amino-acid-long
factor 7), is a maternally expressed gene whose protein prod- T7 viral coat protein tag was inserted at the XbaI and KpnI sites.
uct is retained in the cytoplasm until the MBT, when it The T7 viral coat peptide was used to distinguish the exogenous
reenters the embryonic nucleus (Dreyer et al., 1983; Miller xnf7 from the endogenous protein with polyclonal antibodies. The
xnf7-8 cDNA lacks 30 N-terminal amino acids of the full-lengthet al., 1989, 1991; Reddy et al., 1991). xnf7 is a member of
cDNA to ensure use of the globin translational start site (Reddy eta novel family of zinc ®nger proteins, the B-box family,
al., 1991). It was cloned into the EcoRI site of the vector, fusing itconsisting mainly of transcription factors and protoonco-
in frame with the upstream T7 sequence. Point mutations in thegenes (Reddy and Etkin, 1991; Reddy et al., 1992). From its
threonines of the phosphorylation sites were made by PCR withdomain structure, its ability to bind to DNA, and the ability
synthetic oligonucleotides containing the mutations (see Li et al.,of the N-terminal acidic domain to trans-activate a reporter
1994b, for details of the constructs). Synthetic capped RNAs were
gene we believe that xnf7 functions, either by itself or in prepared from these constructs using SP6 RNA polymerase (mMes-
conjunction with other proteins, as a transcription factor sage mMachine; Ambion) and puri®ed on G-50 Sephadex spun col-
(Li et al., 1994b; Reddy et al., 1991). In addition, members umns followed by isopropanol precipitation.
of the B box zinc ®nger gene family, including xnf7 (Shou
et al., 1996) and PML (Dyke et al., 1994), form homo- and
heterodimers suggesting that protein±protein interactions Microinjection of embryos
are important in their functioning.
xnf7 is retained in the cytoplasm during early develop- Eggs were fertilized in vitro, dejellied in 2% cysteine solution
(pH 7.8), and transferred into 11modi®ed Barth saline (MBS). Afterment by an anchor mechanism that depends on the presence
being washed with 11 MBS 3±5 times, the eggs were transferredof a 22-amino-acid cytoplasmic retention domain (CRD)
into 3% Ficoll (Ficoll 400, Pharmacia) and microinjected as pre-and the phosphorylation of two sites: site 1, consisting of
viously described (Etkin et al., 1984; Etkin and Pearman, 1987).the threonine located at amino acid 103, and site 2, con-
From 1.5 to 5 ng of RNA was injected into the equatorial regionsisting of threonines at amino acids 209, 212, and 218 (Li
of the fertilized eggs. For correction experiments, the RNA of the
and Etkin, 1993; Li et al., 1994a). We showed the role of wild-type and mutant xnf7 were mixed in the ratio of 0.5:1, 1:1,
phosphorylation in retention by mutating the threonines at and 2:1, and then coinjected. Both dorsal and ventral cells of the
sites 1 and 2 to glutamic acids (dnxnf7), which mimicked four-celled embryos were injected with 1 ng of RNA. Three hours
a permanent state of phosphorylation, or to alanines, which after microinjection, embryos were transferred into 0.11 MBS and
allowed to develop.cannot be phosphorylated. The dnxnf7 mutation resulted
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Whole-Mount in Situ Hybridization of a 22 amino acid CRD and the phosphorylation of two
sites (sites 1 and 2) within the protein. Those experimentsWhole-mount in situ hybridizations using Xbra, chordin, Xwnt8,
were performed by injecting into embryos an epitope-taggedand Mix probes were performed as described by Harland (1991)
with the following changes: (1) after initial ®xation, embryos were mutant form of xnf7 mRNA in which the threonines of
dehydrated and stored in ethanol to reduce nonspeci®c staining sites 1 and 2 were changed to glutamic acids to mimic a
in internal cavities; (2) hybridization reactions and washes were permanent state of phosphorylation (designated xnf7thr-glu
performed at 607C; (3) wash steps involving 50 and 25% hybridiza- or dnxnf7; Shou et al., 1996). They showed that the xnf7thr-
tion buffer were omitted; (4) Chaps was omitted from SSC washes; glu protein remained in the cytoplasm until the late neurula
(5) nonspeci®cally bound antidigoxigenin antibody was removed stage, indicating that the cytoplasmic retention machineryby washing six times for 30 min each in maleic acid buffer; (6) the
was functional until that time. Figures 1A and 1B show theRNase A incubation was omitted; and (7) BM purple (Boehringer-
results of a similar experiment in which mRNAs for theMannheim Biochemicals) was used as the alkaline phosphatase
xnf7thr-glu mutant and wild-type xnf7-8 were injected intosubstrate (either overnight at 47C or for 1±2 hr at 377C) for embryos
the fertilized egg. Embryos were raised until stage 10, ®xed,probed for Xwnt8 and Mix expression. Digoxigenin-labeled probes
were prepared from the following plasmid constructs: pSP73±Xbra sectioned, and immunostained using the T7 epitope tag an-
(Smith et al., 1991), pBS(SK)±chordin (Sasai et al., 1994), pGEM± tibody to detect the exogenous xnf7 protein. It is clear that
Xwnt8 (Christian et al., 1991), or pXvent1 (Gawantka et al., 1995). the mutant xnf7thr-glu was cytoplasmic, whereas the wild-
Xwnt8 and Xvent1 probes were hydrolyzed for 35±40 min at 607C type xnf7-8 protein was nuclear indicating that the xnf7thr-
in 40 mM NaHCO3, 60 mM Na2CO3 (pH 10.3), neutralized by glu protein was retained in the cytoplasm past the MBT.
addition of an equal volume of 0.2 M sodium acetate, 10 mM DTT, The behavior of the exogenous xnf7-8 wild-type protein was1% glacial acetic acid, and precipitated. In situ hybridizations using
the same as that of the endogenous xnf7 protein (Li andthe Xvent1 probe were performed as described by Gawantka et al.
Etkin, 1993; Li et al., 1994a,b; Shou et al., 1996). These data(1995).
indicate that the xnf7thr-glu mutant mimics a constitu-Green ¯uorescent protein (GFP) mRNA was prepared from lin-
tively phosphorylated form of the protein and is retained inearized plasmid SGP as described above (Rubenstein et al., 1997).
GFP mRNA was mixed with dnxnf7 mRNA to ®nal concentrations the cytoplasm past the MBT.
of 0.1 and 0.5 mg/ml, respectively, and embryos were injected with
10 nl of the mixture as described above. GFP expression was visual-
The dnxnf7 Acts as a Dominant Negative Mutantized using a ¯uorescent microscope and a FITC ®lter.
and Interferes with the Translocation of the
Immunostaining of Embryos Endogenous xnf7 Protein
Embryos were ®xed in 100% methanol at 47C overnight, embed- Evidence from studies with B-box zinc ®nger family
ded in Paraplast Plus (Monoject), and serially sectioned into 10-mm
members PML (Dyke et al., 1994), rfp (Takahashi et al.,sections. Immunoperoxidase staining was carried out according to
1988; Cao et al., 1997), and xnf7 (Shou et al., 1996) indi-Li et al. (1994a). Deparaf®nized and hydrated sections were
cated that they formed homodimers. In addition, recent evi-bleached in 6% hydrogen peroxide in methanol for 20±30 min.
dence suggests that xnf7 is found in a large complex con-Following two 10-min phosphate-buffered saline (PBS) washes, non-
sisting of dimers of xnf7 and several other proteins (Kuangspeci®c staining was blocked with a 1-hr incubation in a blocking
buffer consisting of 10% goat serum and 3% BSA in TBS with 0.5% and Etkin, unpublished data). We also demonstrated that
Tween 20 (TBST). Sections were incubated 1 hr in a 1:50±1:200 when the xnf7thr-glu was overexpressed in oocytes, it inter-
dilution of the L24 pAb (Reddy et al., 1991) in blocking buffer and fered with the accumulation of the newly synthesized en-
then washed two times for 10 min each in PBS. For control sections, dogenous xnf7 in the GV (Shou et al., 1996). This suggested
no primary antibody was used. The sections were treated with the that the overexpressed xnf7thr-glu protein had the potential
secondary antibody (1:50 dilution of goat anti-rabbit conjugated
to act as a dominant-negative mutant by forming dimerswith peroxidase) for 1 hr and washed two times for 10 min in PBS.
with the endogenous xnf7 protein and anchoring it in theThe color reaction was initiated with 1 mg/ml DAB / 0.03% H2O2
cytoplasm. Thus, we now refer to the xnf7thr-glu mutantin PBS for 5 min and was stopped by two 5-min washes with water.
as dnxnf7.The sections were counterstained with either hematoxylin or azure
Therefore, we tested the ability of overexpressed dnxnf7B and mounted with Permount (Fisher) or a 1:1 dilution of PBS
with glycerol. protein to inhibit the nuclear localization of the endogenous
Some embryos were subjected to in situ hybridization and subse- xnf7 protein after the MBT in developing embryos. dnxnf7
quent immunostaining using an alkaline phosphatase-conjugated mRNA was injected into one of the blastomeres of a two-
anti-T7 tag antibody (Novagen) as above. Color development was celled embryo to limit its area of expression in the embryo.
performed using Vector red alkaline phosphatase substrate (Vector The resulting embryos were allowed to develop to stage 9.5,
Labs) according to manufacturer's directions and halted by incuba-
well past the MBT. Embryos were sectioned and alternatetion for at least 1 hr in MEMFA.
serial sections were stained with the T7 epitope tag anti-
body (recognizes only the exogenous protein) and the L24RESULTS
antibody (recognizes both endogenous and exogenous xnf7
Exogenous dnxnf7 Protein Remains in the protein). Figure 2A is a section treated with the T7 antibody
Cytoplasm after the MBT showing that the dnxnf7 protein was, as expected, expressed
in only a portion of the embryo. The exogenous dnxnf7Li et al. (1994b) showed that the cytoplasmic retention
of xnf7 prior to the MBT was dependent upon the presence protein was detected in the cytoplasm in stage 9.5 embryos
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FIG. 1. The mutation of phosphorylation sites 1 and 2 to glutamic acid results in retention of xnf7 in the cytoplasm. Synthetic mRNA
from the dnxnf7 mutant was injected into fertilized eggs and analyzed for the presence of exogenous xnf7 using the T7 epitope tag antibody.
(A) Sections of embryos at stage 10 that were injected with the dnxnf7 mRNA. (B) Embryos at stage 10 that were injected with the xnf7-
8 (wild-type) mRNA. The arrows point to the nuclei, and the constructs are diagrammed below. CRD, cytoplasmic retention domain
(stippled box); NLS, nuclear localization signal (dotted circle); Ring-®nger and B-box zinc ®nger domains (open boxes); striped ovals are
phosphorylation sites; open ovals are mutated phosphorylation sites 1 and 2.
past the MBT (Fig. 2A, inset). Figure 2B shows a subsequent its mRNA into fertilized eggs prior to ®rst cleavage and
examined the developing embryos for the appearance of aserial section from the same embryo that was stained using
phenotype. Both the control embryos injected with xnf7-8the L24 antibody. It is clear that the endogenous xnf7 pro-
mRNA (wild-type) and the embryos injected with thetein was in the cytoplasm in the region where the dnxnf7
dnxnf7 mRNA developed normally until stages 10±11 (gas-protein was detected; however, the endogenous xnf7 protein
trulation). Although the dorsal lip of the blastopore ap-was located in the nucleus in the remainder of the embryo.
peared at the same time in control and experimental em-These results suggest that the dnxnf7 protein inhibited the
bryos (Fig. 3A), it became apparent that late gastrulationnuclear localization of the endogenous xnf7 protein in areas
movements of the ventral and lateral blastopore lips werewhere it was expressed, thus acting as a dominant-negative
slightly retarded in some of the embryos injected with themutation.
dnxnf7 mRNA. These embryos exhibited various anterior
abnormalities, including microcephaly, acephaly, and a lackOverexpression of the dnxnf7 Protein in of some dorsal structures (Fig. 3B). These embryos fellDeveloping Embryos Results in a Mixture within the DAI (dorsal±anterior index) range of 2±4 (Kao
of Ventralized and Dorsalized Embryos and Elinson, 1988) and were categorized as ventralized em-
We took advantage of the dominant-negative nature of the bryos, although in the majority of the cases the embryos
lacked only anterior structures from the otocyst forward.dnxnf7 protein to assess the function of xnf7. We injected
FIG. 2. dnxnf7 protein acts as a dominant-negative mutant to retain the endogenous protein in the cytoplasm past the MBT. dnxnf7
mRNA was injected into one of the blastomeres of a two-celled embryo to limit its area of expression in the embryo. The resulting
embryos were allowed to develop to stage 9.5, past the MBT. Embryos were sectioned and alternate serial sections were stained with the
T7 epitope tag antibody (recognizes only the exogenous protein) and the L24 antibody (recognizes both endogenous and exogenous xnf7
protein). (A) A section stained with the T7 antibody showing that the dnxnf7 protein was, as expected, expressed in only a portion of the
embryo. In this section we detected the exogenous dnxnf7 protein in the cytoplasm even though this is after the MBT (inset). (B) A
subsequent serial section from the same embryo that was stained using the L24 antibody. Arrows point to nuclei.
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FIG. 3. Dorsalized and ventralized phenotypes developed from embryos injected with the dnxnf7 mRNA. Fertilized eggs were injected
with 1.5 ng of the mutant dnxnf7 mRNA prior to ®rst cleavage. Injected embryos were allowed to develop to various stages to identify
any mutant phenotypes. (A) The appearance of the dorsal lip in both control (xnf7-8 injected) (c) and dnxnf7 mRNA-injected embryos (m).
(B) Appearance of the dorsalized and ventralized phenotypes in dnxnf7-injected embryos. The top diagram is the DAI (dorsal±anterior
index scale taken from Kao and Elinson, 1988). To the left are ventralized embryos of DAI 2±3 while on the right are dorsalized embryos
DAI 7±8. A normal stage 28 embryo is shown for comparison. The arrows point to the cement gland or the anterior portion of the embryo
when the cement gland is absent.
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TABLE 1 7±8 and 18% DAI of 6), and 58% were normal. When in-
Overexpression of dnxnf7 during Xenopus Development Results jected in a 1:2 ratio (1.5 ng mutant xnf7 and 3 ng wild-
in Defects in Dorsal/Ventral Patterning type), we observed 0% ventralized, 2% with severe DAI 7±
8 dorsalized phenotypes, 25% with mild DAI 6 dorsalized
RNA injected phenotype, and 73% normal embryos. Although we see a
signi®cant amount of correction of the dorsalized pheno-wt dn
type by overexpression of the wild-type xnf7, it is interest-
Dosage (ng): 1.5 5 1.5 5 ing that this phenotype was more dif®cult to correct (i.e.,
even at the highest doses of xnf7 wild-type, there were still
Number of embryos 155 140 182 341
25% DAI 6 embryos). It is not clear why this occurred;Ventralized (DAI:
however, it may indicate that the dorsalized phenotype is2±4) 2 (1%) 7 (5%) 99 (54%) 149 (43%)
more prevalent over the ventralized phenotype. Regardless,Dorsalized (DAI:
these results show that the phenotype caused by the domi-6±8) 0 0 53 (30%) 134 (40%)
Normal 153 (99%) 133 (95%) 30 (16%) 58 (17%) nant negative mutant dnxnf7 was corrected with increasing
doses of wild-type xnf7-8 mRNA, which supports our con-
Note. Embryos were injected with xnf7wt or dn mutant RNA at clusion that the mutant phenotype was the result of inter-
the two-cell stage and scored for dorsal/ventral patterning defects ference with a normal biological process and not a technical
at tailbud stage.
artifact.
Injection of dnxnf7 mRNA into Dorsal Blastomeres
Other embryos injected with dnxnf7 RNA developed into Results in Ventralized Embryos, Whereas
typically dorsalized embryos of the DAI range 6±8, similar Injection into Ventral Blastomeres Results
to embryos treated with lithium (Figs. 3B and 3C). The most in Dorsalized Embryos
severely affected completely lacked a trunk but had head
structures such as eyes and cement glands. There were no It was possible that the two classes of phenotypes which
we found were caused by differences in the site of injectionsomites visible, but the embryos possessed enlarged noto-
chords (data not shown). Table 1 indicates that at two differ- of the dnxnf7 mRNA in the egg. To test this we injected
the mutant dnxnf7 and wild-type xnf7-8 mRNA into theent doses of injected dnxnf7 mRNA (1.5 and 5 ng/embryo)
between 43 and 54% of the embryos were ventralized and future dorsal and ventral blastomeres of the four-celled em-
bryo. These sites were selected since it was found thatbetween 30 and 40% showed the dorsalized phenotype. In
control embryos 5% showed minor ventralized and none mRNAs for gsc and xwnt8 (among numerous others) in-
duced a secondary axis only when injected into the ventralshowed dorsalized phenotypes.
We also injected a mutant xnf7 mRNA that encoded a blastomeres (Sokol et al., 1991; Smith and Harland, 1991;
Cho et al., 1991).protein in which the threonines at phosphorylation sites 1
and 2 were mutated to alanines (xnf7thr-ala). We previously Of the embryos injected in the dorsal blastomeres, 44%
were ventralized while 6% were dorsalized (Table 3). Onshowed that this mutant protein enters the nucleus prior
to the MBT (Li et al., 1994a). Embryos injected with the the other hand, 12% of the embryos injected into the ventral
cells were ventralized while 45% developed as dorsalizedxnf7thr-ala mutant developed normally (Table 1). This
strongly suggests that xnf7 cannot function in nucleus prior
to the MBT, perhaps due to the requirement for a cofactor
that is not available until after the MBT.
TABLE 2
Correction of dnxnf7-Induced Phenotypes
Mutant Embryos Are Rescued by Coinjection of
RNA injectedWild-Type xnf7-8 and dnxnf7 mRNAs
wt / dnTo eliminate the possibility that the mutant phenotypes
wt dn
were caused by a nonspeci®c injection artifact we attempted Dosage (ng): 3 1.5 1.5 / 1.5 3 / 1.5
to rescue the normal phenotype in mutant embryos by coin-
Number of embryos 97 160 90 229jecting increasing amounts of the wild-type exogenous xnf7-
Ventralized 0 22 (14%) 2 (2%) 08 mRNA along with the mutant dnxnf7 mRNA. Injection
Dorsalizedof the dnxnf7 mRNA (1.5 ng/embryo) resulted in a 14%
DAI8 0 86 (54%) 19 (22%) 5 (2%)incidence of ventralized embryos, a 72% incidence of the
DAI6 0 30 (18%) 17 (18%) 57 (25%)dorsalized phenotype (54% DAI of 7±8 and 18% DAI of 6),
Normal 97 22 (14%) 52 (58%) 167 (73%)and a 14% incidence of the normal phenotype (Table 2).
When dnxnf7 mRNA was mixed with an equal amount of Note. Embryos were injected with xnf7wt or dn mutant RNA at
xnf7-8 mRNA, only 2% of the embryos were ventralized, the two-cell stage and scored for dorsal/ventral patterning defects
at tailbud stage.40% showed the dorsalized phenotype (22% showed DAI
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TABLE 3 mesodermal markers such as the panmesodermal marker
Correlation between Site of Injection of dnxnf7 RNA Xbra (Smith et al., 1991), the dorsal marker chordin (Sasai
and Phenotype et al., 1994), and the ventral marker Xvent1 (Gawantka et
al., 1995).
Site of injection To perform these experiments we injected dnxnf7 into
either the dorsal or ventral blastomeres of a four-celled em-Dorsal Ventral
bryo. Gastrula-stage embryos were analyzed by in situ hy-
Number of embryos 36 124 bridization to determine the pattern of expression of Xbra
Ventralized 16 (44%) 14 (12%) in injected and noninjected embryos. Xbra is expressed as
Dorsalized 2 (6%) 56 (45%) a complete ring around the blastopore during gastrulation
Normal 18 (50%) 53 (43%) (Smith et al., 1991). Figures 6A and 6C show that overex-
pression of wild-type xnf7-8 into either the dorsal or ventralNote. Embryos were injected with xnf7dn mutant RNA into two
blastomeres did not interfere with the expression patterneither dorsal or ventral blastomeres at the four-cell stage and scored
for dorsal/ventral patterning defects at tailbud stage. of Xbra in stage 10.5 embryos. However, when dnxnf7 was
overexpressed in the dorsal (Fig. 6B) or ventral (Fig. 6D)
regions, it inhibited the expression of Xbra. Immunostain-
ing of embryos with an antibody against the epitope tagembryos (Table 3). These results demonstrate that the site
on wild-type xnf7-8 (anti-T7 tag) showed a de®nite overlapof injection of the dnxnf7 mRNA determined the phenotype
between the overexpressed xnf7 protein and the Xbra RNAof the embryos.
(Fig. 6E). When embryos that were injected with dnxnf7Further examples of the range of dorsalized and ven-
were analyzed, they showed an overlap between dnxnf7 pro-tralized embryos produced by injection of dnxnf7 RNA into
tein and the area where Xbra RNA was inhibited (Fig. 6F).the dorsal or ventral blastomeres are shown in Fig. 4. A
dnxnf7 expression in regions other than the blastopore ringlarge number of the dorsalized embryos fell within the DAI
(e.g., animal pole) did not interfere with the normal patternrange of 6±7 in which the anterior±posterior body axis is
of Xbra expression (data not shown). This suggests that toshortened. The DAI scale was developed using UV and lith-
interfere with the expression of downstream genes, such asium treatment to produce ventralized and dorsalized em-
Xbra, dnxnf7 must be expressed in the same cells as thebryos, respectively. The dnxnf7-induced phenotypes, al-
marker gene being analyzed. This could explain the rela-though resembling those produced by UV or lithium, may
tively low penetrance or variability of the phenotypes inbe produced through different mechanisms or pathways.
dnxnf7-injected embryos in some experiments.This is supported by preliminary results showing that
We also tested the effect of overexpression of dnxnf7 on thednxnf7 cannot correct UV or lithium-treated embryos when
expression of the dorsal marker chordin. Chordin is expressedoverexpressed in the appropriate cell lineages (Nakamura,
®rst at the early gastrula stage of development in the dorsalEl-Hodiri, and Etkin, unpublished observations).
lip of the blastopore (Sasai et al., 1994). Figures 7A and 7CWe also noted variation in the penetrance of both the
show the pattern of chordin expression in stage 10.5 embryosdorsalized and ventralized phenotypes of dnxnf7-injected
in which the wild-type xnf7-8 protein was overexpressed inembryos in different experiments. We attribute this to: (1)
the dorsal and ventral blastomeres, respectively. Figure 7Bthe necessity to target the dnxnf7 to speci®c blastomeres
shows a stage 10.5 embryo that was injected with dnxnf7 inand (2) the necessity to produce large enough amounts of
the dorsal side. There appears to be a clear decrease or absencednxnf7 protein to interact with and retain all of the endoge-
of chordin expression. This is consistent with the injectionnous xnf7 protein.
of dnxnf7 in this region resulting in ventralized embryos or
dnxnf7 Does Not Effect Cell Viability embryos lacking anterior structures. When dnxnf7 was ex-
pressed in the ventral region of the embryo, it resulted indnxnf7 may exert its affect by inhibiting the viability of
an increased domain of chordin expression characterized bycells resulting in a decreased number of cells contributing
chordin expression in cells along the marginal zone sur-to either the dorsal or ventral regions of the embryo. To
rounding the blastopore (Fig. 7D).test this possibility we coinjected mRNA for the green ¯u-
The effect of dnxnf7 overexpression on the domain oforescent protein (GFP) along with the dnxnf7 mRNA. Figure
ventral marker Xvent1 (Fig. 8) expression was also analyzed.5 shows that cells expressing GFP populate a large portion
Xvent1 is expressed around the blastopore with a gap atof a dorsalized embryo that was injected with both mRNAs.
the dorsal most region (Fig. 8A) (Gawantka et al., 1995).In addition, we can detect the presence of dnxnf7 protein
Overexpression of wild-type xnf7-8 in either the dorsal orin injected embryos by immunostaining (Fig. 6). Thus, it is
ventral region had no effect on the expression of this geneclear that the mechanism of action of dnxnf7 is not through
(Figs. 8B and 8C). Overexpression of dnxnf7 in the dorsalits effect on cell viability.
blastomeres had no effect on Xvent expression (Fig. 8D);
dnxnf7 Affects the Expression of Mesodermal however, overexpression in the ventral blastomeres reduced
Markers or inhibited Xvent1 expression (Figs. 8E and 8F). These re-
sults are consistent with the observed phenotype in whichTo further characterize the effect of dnxnf7 on dorsal/
ventral patterning we analyzed the expression of various dnxnf7 injected into ventral blastomeres results in dor-
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FIG. 4. Injection of dnxnf7 mRNA into the future dorsal and ventral blastomeres produces a range of dorsalized and ventralized
phenotypes. A, C, and E are embryos exhibiting various degrees of dorsalization produced by injection of dnxnf7 mRNA into the
ventral blastomeres of the four-celled embryo. Notice a gradual shortening of the anterior±posterior axis to yield the dorsalized
embryo. These fall between the ranges of DAI 6±7. B, D, and F are embryos resulting from the injection of dnxnf7 mRNA into the
dorsal blastomeres of the four-celled embryo. They range in ventralized phenotypes from DAI 1±3. The arrows point to the cement
gland or the anterior of the embryo when the cement gland is absent as in the ventralized embryos in B, D, and F.
FIG. 5. Overexpression of dnxnf7 does not affect cell viability. Embryos were coinjected with a mixture of dnxnf7 and green ¯uorescent
protein (GFP) mRNA in the ventral blastomeres. An example of a stage 35 dorsalized embryo is shown in A. B is a diagram of the embryo
showing the distribution of the GFP. Other light areas of the embryo are due to auto¯uorescence of the yolk (dorsal side up).
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FIG. 7. Dnxnf7 affects the expression of the dorsal mesodermal patterning gene chordin. Embryos injected in the dorsal blastomeres (A)
or the ventral blastomeres (C) with wild-type xnf7-8 and analyzed for chordin expression. Embryo injected with dnxnf7 in the future
dorsal blastomeres showing a loss of chordin expression (B). Embryo injected with the dnxnf7 into the future ventral blastomeres showing
an increase in the chordin domain (D). The arrows in D de®ne the extent of the chordin expression domain. Dorsal side of the embryos
is up.
FIG. 6. Overexpression of dnxnf7 affects the expression of the pan-mesodermal marker Xbra. In situ hybridization analysis of embryos
injected with wild-type xnf7-8 in the dorsal (A) or ventral (C) blastomeres showing Xbra expression at stage 10.5. Xbra expression was
also analyzed in embryos injected with dnxnf7 in the future dorsal region (B) and in the future ventral region (D). In addition, we also
immunostained embryos using an alkaline phosphatase-conjugated anti-T7 Tag antibody (E and F, red color). (E) Immunostaining of the
embryos injected in dorsal blastomeres with wild-type xnf7-8. (F) Embryo injected with dnxnf7 in the dorsal blastomeres. Dorsal side of
embryos is up and arrows point to the gap in Xbra expression.
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salized embryos. Similar results were observed with another Preliminary data indicate that overexpressed dnxnf7 alters
the sensitivity of animal caps to activin indicating the po-ventrolateral mesodermal marker, Xwnt8 (Christian and
Moon, 1993) (data not shown). The lack of effect of dnxnf7 tential involvement of xnf7 in a similar growth factor path-
way (El-Hodiri, Shou, and Etkin, unpublished observations).in the dorsal blastomeres on either Xvent1 or Xwnt8 sug-
gests that the observed phenotype more closely represents It is clear that the molecules involved in embryonic pat-
terning interact in an integrated network of synergistica posteriorized embryo lacking anterior structures but still
possessing most of the ventral and posterior portions of the (Kimmelman et al., 1992) and antagonistic (Hemmati-Bri-
vanlou et al., 1994; Piccolo et al., 1996; Zimmerman et al.,embryo.
Homeobox genes Mix.1 and Mix.2 also have been impli- 1996) interactions and concentration gradients (Green et al.,
1992; Niehrs et al., 1994). It was shown that coexpressioncated in dorsal/ventral patterning of the mesoderm (Rosa,
1989; Huang et al., 1995). Overexpression of dnxnf7 in ei- of Xbra with noggin in animal caps causes dorsal mesoderm
formation (muscle, notochord, and neural tissue), whilether the dorsal or ventral blastomeres did not interfere with
the expression of these genes (data not shown). This sug- coexpression of Xbra with Xwnt 8 results in conversion to
muscle masses (Cunliffe and Smith, 1994). Neither Xbragests that the Mix genes may be regulated through a differ-
ent mesodermal patterning pathway than xnf7 functions. nor Xwnt 8 nor noggin causes dorsal mesoderm formation
when expressed alone indicating an interaction betweenIn addition, this result also indicates that xnf7 does not
function as a global transcriptional regulator involved in these gene products. By inhibiting the expression of gene
products such as Xbra in different regions of the embryothe regulation of all genes at the MBT but functions in
regulating a speci®c subset of genes. dnxnf7 may alter the ratio of Xbra to other factors thus
effecting the patterning of the mesoderm to achieve eitherThe analysis of the effect of dnxnf7 on mesodermal mark-
ers indicate that the dnxnf7, in addition to in¯uencing an abnormal dorsal or ventral fate. Additionally, the effect
of dnxnf7 on the mesodermal patterning genes chordin andD/V patterning at the morphological level, also affects the
regulation of several mesodermal markers. In several hun- Xwnt8 indicates an involvement of xnf7, either directly or
indirectly, in the pathways regulating these genes.dred dnxnf7-injected embryos in which dorsal/ventral
markers were analyzed we clearly detected effects in a 20±
30% of the samples. This was consistent with the extent
xnf7 May Serve as an Intermediate between Signalof the observed D/V defects.
Transduction Pathways and the Expression of
Region-Speci®c Patterning Genes That Are
Expressed at the Gastrula Stage
DISCUSSION
There is a growing list of proteins that are regulated by
their selective retention in the cytoplasm either during spe-General Mechanisms of Mesoderm Patterning
ci®c stages of the cell cycle, cell differentiation, or different
developmental stages (Whiteside and Goodbourne, 1993;A large number of molecules have been identi®ed that
can in¯uence the axial patterning of the Xenopus embryo. Shou et al., 1996). Xnf7 is retained in the cytoplasm until
the MBT by a mechanism involving a 22-amino-acid cis-These include a number of maternal RNAs that are local-
ized at the vegetal cortex of the oocyte and other as yet acting cytoplasmic retention domain (CRD) and the phos-
phorylation of two sites within the protein (Li et al., 1994a).unidenti®ed localized and unlocalized maternal compo-
nents. We believe that these establish a prepattern which This is a novel mechanism that entails the interaction of
xnf7 with a cytoplasmic anchor. Additionally, we haveforeshadows the visible axis of the future embryo. Activin-
like and FGF-like pathways also are critical components in shown that xnf7 is associated with a high-molecular-weight
protein core complex of 670 kDa (Shou et al., 1996) andthe early patterning of the embryo. It appears that these
pathways interact with one another since activin is less that it also associates transiently with at least three other
proteins at different times and in different subcellular com-effective in inducing mesoderm in embryos expressing a
dominant-negative FGF receptor (LaBonne and Whitman, partments during embryogenesis (Nakamura, Wu, and Et-
kin, unpublished observations). It is clear that cytoplasmic1994; Cornell and Kimmelman, 1994) and FGF affects the
concentration of activin necessary to activate the muscle retention is utilized as a strategy in other pathways such
as the TGFb/Smad which regulate patterning of the earlyactin gene in animal caps (Green et al., 1992). Follistatin
may also regulate the function of activin through an antago- embryo. Thus, xnf7 represents a another pathway involved
in mesodermal patterning that utilizes cytoplasmic reten-nistic interaction (Hemmati-Brivanlou and Melton, 1994).
FIG. 8. dnxnf7 overexpression affects the expression of the mesodermal patterning gene Xvent-1. (A) In situ hybridization pattern of
Xvent1 expression in uninjected stage 10 embryos. Embryos injected with wild-type xnf7-8 in the dorsal (B) and ventral (C) regions and
analyzed for Xvent1 expression. Embryos injected with dnxnf7 in the dorsal (D) region and analyzed for Xvent1 expression. Embryo injected
with dnxnf7 in the ventral (E) region and analyzed for Xvent1 expression. (F) Ventral view of the embryo shown in E to show gap in
Xvent1 expression.
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tion as a mechanism of regulation. Both of these pathways
are regulated by changes in the state of phosphorylation of
the components; therefore, it will be interesting to dissect
any interactions or cross-talk between them.
The overexpressed exogenous dnxnf7 protein inhibits the
translocation of the endogenous protein into nuclei at the
MBT, probably through sequestration in the large cyto-
plasmic complex of which endogenous xnf7 is a component
(Shou et al., 1996). The inability of the endogenous xnf7
to enter the nucleus at the MBT resulted in a phenotype
consisting of a mixture of dorsalized and ventralized±poste-
riorized embryos. The ventralized or posteriorized pheno-
type was induced when the dnxnf7 RNA was injected into
the dorsal blastomeres of the four-celled embryo, while in-
jection into the ventral blastomeres resulted in the dor-
salized phenotype. The expression of the mesodermal
marker Xbra was disrupted wherever dnxnf7 was expressed.
Also expression of dnxnf7 in the dorsal blastomeres inhib-
ited the dorsal expression of chordin. On the other hand,
overexpression of dnxnf7 in the ventral blastomeres ex-
panded the chordin expression domain and inhibited the
expression of Xwnt8 and Xvent1 in the ventral region of
the embryo. Interestingly, we found that the overexpressed
dnxnf7 in the dorsal blastomeres did not affect the expres-
sion of ventral markers such as Xvent1 and Xwnt8. Taken
together with the preponderance of dorsalized embryos ob-
FIG. 9. Summary of the role of xnf7 in D/V patterning. xnf7 isserved in many of the experiments, it suggests that the in-
phosphorylated during oocyte maturation by several different ki-
jection of dnxnf7 may preferentially result in the dorsaliza- nases at two sites. This results in its retention in the cytoplasm in
tion rather than ventralization. Regardless, these data indi- a 670-kDa complex (Shou et al., 1996). It remains cytoplasmic until
cate that the entry of xnf7 into the nucleus at the MBT, the MBT when it is dephosphorylated and enters the nucleus. We
which is controlled by its state of phosphorylation, is criti- speculate that other components interact with xnf7 in nuclei
within different regions of the embryo, resulting in the regulationcal for normal dorsal±ventral pattern of region-speci®c gene
of genes giving mesoderm a dorsal/ventral character. xnf7 probablyexpression in the embryo.
functions in parallel with other mesodermal regulatory pathways.Recent results indicate that the state of phosphorylation
of xnf7 is regulated by several different kinases including
cyclin-dependent kinases and MAP kinase which phosphor-
ylate sites 1 and 2 differentially (Reddy et al., 1991; El-
Hodiri et al., 1997). Thus, xnf7 may serve as an intermediary tor and regulate immediate-early mesodermal patterning
genes when it enters the nucleus at the MBT. Additionally,between several different signal transduction pathways in-
volved in the regulation of region-speci®c mesodermal gene xnf7 speci®city for regulating both dorsal and ventral pat-
terning genes may be determined through the interactionexpression (Fig. 9). This indicates the likelihood of cross-
talk between these different pathways providing a means with different transcription factors or cofactors within dis-
tinct regions of the embryo to activate genes. This interac-of plasticity and redundancy in regulating mesodermal pat-
terning. tion may be similar to the viral E1A protein when it inter-
acts with members of the ATF family (Liu and Green, 1994).
A recent example of such a mechanism is found in the
How xnf7 May Function in Mesodermal Patterning interaction between DPC4 and either Smad1 or Smad2 re-
sulting in ventralization or dorsalization of the mesoderm,Our data suggest that xnf7 functions in the execution of
a genetic program which gives mesoderm a ventral or dorsal respectively. Alternatively, one could envision xnf7, alone
or in association with different cofactors, functioning as aidentity by regulating the expression of a battery of dorsal/
ventral patterning genes. It is clear that xnf7 is not a general repressor in which it would repress the expression of dorsal
patterning genes in the ventral region, while repressing ven-activator of gene expression at the MBT since the dnxnf7
did not interfere with the expression of the Mix genes and tral patterning genes when in the dorsal region.
This latter possibility is supported by the recent observa-also did not interfere with general cell viability as shown
by expression of the coinjected green ¯uorescent protein in tion that the xnf7 CRD is homologous to the chromodo-
main which is a motif found in a large number of genesdnxnf7-expressing cells. The precise mechanism by which
xnf7 functions is not yet clear; however, there are several such as polycomb which act as repressors through alteration
of chromatin structure (Koonin et al., 1995). Indeed, thepossibilities. xnf7 itself may function as a transcription fac-
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functions in the activin signal transduction pathway. Genes Dev.identi®cation of xnf7 as a component of a high-molecular-
10, 1880±1889.weight protein complex (Shou et al., 1996) supports the idea
Blumberg, B., Wright, C., DeRobertis, E., and Cho, K. (1991). Orga-that it functions in conjunction with other cofactors in reg-
nizer speci®c homeobox genes in Xenopus laevis embryos. Sci-ulating the expression of dorsal or ventral patterning genes
ence 253, 194±196.which is characteristic of chromodomain proteins. This
Cao, T., Borden, K., Freemont, P., and Etkin, L. D. (1997). Involve-
would require the presence of various maternal factors that ment of the rfp tripartite motif in protein±protein interactions
interact with xnf7 in different regions of the embryo. In and subcellular distribution. J. Cell Sci. 110, 1563±1571.
principle, this mechanism could result in the cell autono- Cho, K. W. Y., Blumberg, B., Steinbeisser, H., and De Robertis, M.
mous regulation of mesodermal speci®c genes independent (1991). Molecular nature of Spemann's organizer: The role of the
Xenopus homeobox gene goosecoid. Cell 67, 1111±1120.of inductive interactions (Lemaire and Gurdon, 1994).
Christian, J. L., and Moon, R. T. (1993). Interactions between Xwnt-The dominant-negative strategy has been quite successful
8 and Spemann organizer signalling pathways generate dorsoven-in Xenopus in assessing, among others, the function of the
tral pattern in the embryonic mesoderm of Xenopus. Genes Dev.FGF receptor (Amaya et al., 1991), the activin receptor
7, 13±28.(Hemmati-Brivanlou and Melton, 1992), and Xbra (Rao,
Christian, J. L., McMahon, J. A., McMahon, A. P., and Moon, R. A.1994) in axial patterning. dnxnf7 may function by inhibiting
(1991). Xwnt-8, a Xenopus wnt-1/int-1-related gene responsive
the entry of endogenous xnf7 into the nucleus at the MBT to mesoderm-inducing growth factors may play a role in ventral
or alternatively retaining xnf7-associated transcription fac- mesodermal patterning during embryogenesis. Development
tors or cofactors within the cytoplasm past the MBT. Reten- 111, 1045.
tion of these factors within the ventral region of the embryo Cornell, R., and Kimmelman, D. (1994). Activin mediated meso-
derm induction requires FGF. Development 120, 453±462.(ventral dnxnf7 injections) would alter the regulation of ven-
Cui, Y., Brown, J., Moon, R., and Christian, J. (1995). Xwnt8b: Atral patterning genes resulting in dorsalized embryos. On
maternally expressed Xenopus Wnt gene with the potential rolethe other hand, retention of factors in the dorsal region
in establishing the dorsal ventral axis. Development 121, 2177±(dorsal injection of dnxnf7) would affect the regulation of
2186.the dorsal patterning genes resulting in ventralized em-
Cunliffe, V., and Smith, J. C. (1994). Speci®cation of mesodermalbryos. It is also possible that dnxnf7 may function by alter-
pattern in Xenopus by interactions between Brachyury, noggin,
ing the ratio of such factors within the embryo, thus creat- and Xwnt-8. EMBO J. 13, 349±359.
ing an aberrant gradient of regulatory factors resulting in a Dale, L., Matthews, G., and Colman, A. (1993). Secretion and meso-
dorsalized or ventralized phenotype. derm inducing activity of the TGFb related domain of Xenopus
The dnxnf7 mutant provides us with a tool to explore the vg1. EMBO J. 12, 4471±4480.
Dale, L., Howes, G., Price, B. M. J., and Smith, J. C. (1992). Bonefunction of xnf7 and the broader issue of the molecular basis
morphogenetic protein 4: A ventralizing factor in early Xenopusof dorsal±ventral patterning of the early vertebrate embryo.
development. Development 115, 573±585.It is likely that this analysis will con®rm the role of pre-
Dawid, I. (1994). Intercellular signalling and gene regulation duringviously described molecules and permit us to discover new
early embryogenesis of Xenopus. J. Biol. Chem. 269, 6259±6262.molecules involved in this process.
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